COMPANY

In recent years, the environment surrounding the pharmaceutical industry has undergone rapid changes, and in order to improve the health and efficiency of medical finance, the use of generic drugs and annual drug price revisions are becoming a reality. Product, process, market, supply chain, and organizational innovation power to respond to these changes have become extremely important.

Our company is still young, having been established in 2014, but our staff consists of people with a wealth of experience and knowledge who have been involved in research, manufacturing, quality assurance, and regulatory affairs in the pharmaceutical industry for many years. Utilizing the experience and know-how that we have cultivated over many years, we constantly pursue new added value and provide business innovation that meets the needs of our customers.
In order to maintain close daily contact with overseas drug substance manufacturers and sell high-quality active pharmaceutical ingredients (API), intermediates, pharmaceutical preparations, etc. to the Japanese market, we simply search and import sales of products. In addition, the feature of our work is that we can handle all the services that accompany it, such as support for MF domestic administrators and GMP compliance surveys.

We will make full use of our unique global network to quickly discover active pharmaceutical ingredients, etc. born from outstanding innovations, provide them to the domestic market, and make a sustained contribution.
Under the motto of "Providing added value as a sincere and trusted business partner", we will work together with our business partners as the best partner to respond accurately and quickly to the increasingly sophisticated and diversified needs of users amid new trends. We would like to meet the expectations of our customers without fail and build a stronger relationship of trust with them.

AI Corporation
President Mr. Nobuyuki Morooka